Premium
Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures
Author(s) -
Worley Deanna R.
Publication year - 2014
Publication title -
veterinary and comparative oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.864
H-Index - 34
eISSN - 1476-5829
pISSN - 1476-5810
DOI - 10.1111/j.1476-5829.2012.00354.x
Subject(s) - medicine , lymph , sentinel lymph node , lymph node , stage (stratigraphy) , sampling (signal processing) , pathology , radiology , cancer , biology , paleontology , filter (signal processing) , breast cancer , computer science , computer vision
The study hypothesis is that incorporation of sentinel lymph node ( SLN ) mapping in dogs presenting for mast cell tumour ( MCT ) removal would impact the recommended adjuvant therapy offered. Nineteen dogs were enrolled having either spontaneously occurring or incompletely excised MCTs . Staging included regional lymph node aspiration. SLN mapping was done with regional lymphoscintigraphy combined with intra‐operative lymphoscintigraphy and blue dye. Twenty MCTs in 19 dogs were excised with SLN mapping. Eight dogs had SLNs different from the closest node. Twelve dogs had metastasis in extirpated SLNs , seven occurred in MCTs with a MI ≤ 5. No correlation was noted between patient stage and the c‐ KIT proto‐oncogene. Because of SLN staging, 8 of 19 dogs were offered additional therapy that would have otherwise been excluded. Anatomic sampling of lymph nodes in dogs with MCTs does not accurately reflect which lymph nodes are most likely to be receiving the draining tumour lymph.